CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm
1. Bragar Eagel & Squire is investigating CorMedix for potential securities law violations. 2. CorMedix reported potential net price erosion starting in Q2 2025 during earnings call. 3. The company's stock price dropped after announcing financial results and future price concerns.